Drug Shortage Report for BYETTA
Report ID | 73615 |
Drug Identification Number | 02361817 |
Brand name | BYETTA |
Common or Proper name | exenatide injection |
Company Name | ASTRAZENECA CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | EXENATIDE |
Strength(s) | 250MCG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 1 x 2.4 mL prefilled pen / stylo pré-rempli de 2,4 mL |
ATC code | A10BJ |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-02-05 |
Actual start date | |
Estimated end date | 2019-03-11 |
Actual end date | 2019-04-01 |
Shortage status | Resolved |
Updated date | 2019-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-04-16 | French | Compare |
v9 | 2019-04-16 | English | Compare |
v8 | 2019-02-06 | English | Compare |
v7 | 2019-01-25 | French | Compare |
v6 | 2019-01-25 | English | Compare |
v5 | 2019-01-25 | French | Compare |
v4 | 2019-01-25 | English | Compare |
v3 | 2019-01-25 | French | Compare |
v2 | 2019-01-25 | English | Compare |
v1 | 2019-01-25 | English | Compare |
Showing 1 to 10 of 10